Definium Therapeutics, Inc. (“Definium” or the “Company”), a late-stage clinical biopharmaceutical company developing a new generation of therapies targeting the underlying causes of psychiatric and ...
Kraken parent Payward to buy Bitnomial for up to $550M, adding CFTC-licensed crypto derivatives (perps, options).
Explore Roundhill’s new memory chip ETF: 50% revenue screen targets true DRAM/NAND makers, 2026 shortages boost prices—see if ...
Castor Maritime Inc. (NASDAQ: CTRM) ("Castor" or the "Company"), a diversified global shipping and energy company, today announced its results for ...
Charenton-le-Pont, 16 April 2026 2025 full-year earnings Resilient results despite a sharp slowdown in the global spirits market and some ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results